In this paper, we investigated the insulin-receptor-binding effect of Cassia auriculata flower extract (CFEt) in streptozotocin induced male wistar rats, using circulating erythrocytes as a model system. We measured the levels of plasma glucose and plasma insulin and the binding of insulin to cell-membrane erythrocyte receptors (ER) in CFEt and glibenclamide treated diabetic rats. The mean specific binding of insulin to ER was significantly lower in diabetic control rats than in CFEt, glibenclamide treated diabetic rats, resulting in a significant decrease in plasma insulin. Scatchard plot analysis demonstrated that the decrease in insulin binding was accounted for by a lower number of insulin receptor sites per cell in diabetic control rats when compared with CFEt treated rats. High-affinity (Kd1), low-affinity (Kd2), and kinetic analysis revealed an increase in the average receptor affinity in ER from CFEt treated diabetic rats. The results suggest an acute alteration in the number of insulin receptors on ER membranes in streptozotocin-induced diabetic control rats. Treatment with CFEt (2.40 ± 0.15) improved specific insulin binding, with receptor number and affinity binding diabetic rats (0.95 ± 0.06).These biochemical observations were supplemented by histopathological examination of pancreas section. The data presented here showed that CFEt increase total ER membrane insulin binding sites with a concomitant (7.08 ± 0.51) increase in plasma insulin.
Key words: glucose, insulin binding sites, plasma insulin, Cassia auriculata, glibenclamide.
Copyright © 2021 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0